Proleukin Global Market Report 2025

Proleukin Global Market Report 2025 – By Type (Injection, Powder, Other Types), By Therapeutic Area (Oncology, Immunology, Other Therapeutic Areas), By Clinical Indication (Metastatic Renal Cell Carcinoma (RCC), Non-Small Cell Lung Cancer (NSCLC), Other Indications), By Application (Hospital, Pharmacy), By End-User (Adults, Pediatrics) – Market Size, Trends, And Global Forecast 2025-2034

Name: Proleukin Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Proleukin Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Proleukin Market Definition

Proleukin is the brand name for aldesleukin, a recombinant form of interleukin-2 (IL-2), a naturally occurring protein in the body. Proleukin is classified as a biologic therapy and is primarily used in Oncology and immunotherapy. It works by stimulating the growth and activity of certain white blood cells (lymphocytes), enhancing the immune system's ability to recognize and attack cancer cells.

The main types of proleukin are injection, powder, and others. Proleukin injection is a liquid formulation of aldesleukin, a recombinant interleukin-2 used for immune system modulation. It is used for various clinical indications such as metastatic renal cell carcinoma (RCC), non-small cell lung cancer (NSCLC), other indications, and various therapeutic areas such as oncology, immunology, and others. These are distributed through both online and offline channels. It is applied in hospitals and pharmacies for both adults and pediatrics.

Proleukin Market Segmentation

The proleukinmarket covered in this report is segmented –

1) By Type: Injection, Powder, Other Types

2) By Therapeutic Area: Oncology, Immunology, Other Therapeutic Areas

3) By Clinical Indication: Metastatic Renal Cell Carcinoma (RCC), Non-Small Cell Lung Cancer (NSCLC), Other Indications

4) By Application: Hospital, Pharmacy

5) By End-User: Adults, Pediatrics

Proleukin Market Size and growth rate 2025 to 2029: Graph

Proleukin Market Size 2025 And Growth Rate

The proleukin market size has grown strongly in recent years. It will grow from $1,165.73 million in 2024 to $1,242.46 million in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to increased availability of proleukin in global markets, increased insurance coverage for immunotherapy drugs, growth in physician acceptance of il-2-based treatments, surge in global cancer diagnostics, rising healthcare expenditure in oncology.

Proleukin Market Growth Forecast

The proleukin market size is expected to see strong growth in the next few years. It will grow to $1,581.28 million in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to rising demand for effective treatments in advanced cancer stages, growing demand for advanced treatments for rare cancers, growing clinical evidence supporting proleukin’s efficacy, increasing support from healthcare organizations for immuno-oncology treatments, increasing number of cancer patients. Major trends in the forecast period include advancements in biologic therapies, development of combination therapies using proleukin, technological advancements, strategic collaborations and partnerships, advancements in cancer vaccine development.

Book your 30 minutes free consultation with our research experts

Proleukin Market Driver: Rising Cancer Incidence Fuels Growth In The Proleukin Market

The growing cancer disease is expected to drive the growth of the proleukin market going forward. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells, which can invade nearby tissues and, if untreated, may metastasize to other parts of the body. The increasing prevalence of cancer can be attributed to factors such as an aging population, better detection methods, lifestyle changes, environmental exposures, and improved survival rates, all of which contribute to more people being diagnosed and living with cancer. Proleukin, a high-dose interleukin-2 therapy, helps cancer patients by stimulating the immune system's natural ability to target and destroy cancer cells, offering a potential treatment option for advanced malignancies such as metastatic melanoma and renal cell carcinoma. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, an estimated 20 million new cancer cases and 9.7 million deaths were reported in 2022, with projections suggesting a 77% increase to over 35 million new cases by 2050. Therefore, the growing cancer disease is driving the growth of the proleukin market.

Proleukin Market Driver: Impact Of Increasing R&D Activities On The Growth Of The Proleukin Market

The increasing research and development activities are expected to drive the growth of the proleukin market going forward. Research and development (R&D) activities involve the systematic investigation and innovation aimed at creating new products, improving existing ones, or developing new technologies and solutions through scientific and technical research. Research and development activities are rising due to the growing demand for innovation, technological advancements, and the need to address emerging global challenges in various industries. Research and development activities positively impact Proleukin by enhancing its efficacy, exploring new cancer indications, improving delivery mechanisms, and potentially reducing side effects, thereby broadening its clinical utility and patient reach. For instance, in July 2024, according to the Department of Health and Social Care, a UK-based government department, the business enterprise sector spent $11.3 billion (£9.0 billion) on pharmaceutical research and development in 2022, representing 0.36% of the UK's GDP. Pharmaceutical R&D made up 18% of all business-conducted R&D in the UK that year, the highest share among all product sectors. Therefore, the increasing research and development activities are driving the growth of the proleukin market.

Global Proleukin Market Major Players

Major companies operating in the proleukin market include Novartis Pharmaceuticals Corporation

Proleukin Market Merger And Acquisition: Iovance Biotherapeutics Acquires Proleukin To Strengthen Cancer Immunotherapy Pipeline

In May 2023, Iovance Biotherapeutics, a US-based biotechnology company that develops innovative T-cell-based cancer immunotherapies acquired Proleukin (aldesleukin) from Clinigen Limited for an undisclosed amount. This acquisition enables Iovance Biotherapeutics to enhance its T-cell-based cancer immunotherapy platform by integrating Proleukin (aldesleukin), a key immunotherapy agent, to improve the effectiveness of its tumor-infiltrating lymphocyte (TIL) therapies, thus advancing its pipeline of innovative cancer treatments and strengthening its position in the competitive oncology market. Clinigen Group is a UK-based company that offers Proleukin (aldesleukin).

Regional Outlook For The Global Proleukin Market

North America was the largest region in the proleukin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the proleukin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the proleukin market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Proleukin Market?

The proleukin market consists of sales of cancer vaccines, biosimilars, immune checkpoint inhibitors and adjuvants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Proleukin Industry?

The proleukin market research report is one of a series of new reports from The Business Research Company that provides proleukin market statistics, including proleukin industry global market size, regional shares, competitors with a proleukin market share, detailed proleukin market segments, market trends and opportunities, and any further data you may need to thrive in the proleukin industry. This proleukin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Proleukin Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	CAGR of 6.3% from 2025 to 2034
Revenue Forecast In 2034	2024
Growth Rate	2019-2024
Base Year For Estimation	2025 - 2029 - 2034
Actual Estimates/Historical Data	Revenue in USD Billion and CAGR from 2025 to 2034
Forecast Period	1) By Type: Injection, Powder, Other Types 2) By Therapeutic Area: Oncology, Immunology, Other Therapeutic Areas 3) By Clinical Indication: Metastatic Renal Cell Carcinoma (RCC), Non-Small Cell Lung Cancer (NSCLC), Other Indications 4) By Application: Hospital, Pharmacy 5) By End-User: Adults, Pediatrics
Market Representation	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Segments Covered	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Regional Scope	Novartis Pharmaceuticals Corporation
Country Scope	Request for Sample
Key Companies Profiled	Explore Purchase Options
Customization Scope
Pricing And Purchase Options

1. Executive Summary

2. Proleukin Market Characteristics

3. Proleukin Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Proleukin Market Trends And Strategies

5. Proleukin Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Proleukin Growth Analysis And Strategic Analysis Framework

6.1. Global Proleukin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Proleukin Market Growth Rate Analysis

6.4. Global Proleukin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

6.5. Global Proleukin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

6.6. Global Proleukin Total Addressable Market (TAM)

7. Global Proleukin Market Pricing Analysis & Forecasts

8. Proleukin Market Segmentation

8.1. Global Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Injection

Powder

Other Types

8.2. Global Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oncology

Immunology

Other Therapeutic Areas

8.3. Global Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Metastatic Renal Cell Carcinoma (RCC)

Non-Small Cell Lung Cancer (NSCLC)

Other Indications

8.4. Global Proleukin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital

Pharmacy

8.5. Global Proleukin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Adults

Pediatrics

9. Global Proleukin Market Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Proleukin Market Regional And Country Analysis

10.1. Global Proleukin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. Global Proleukin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Proleukin Market

11.1. Asia-Pacific Proleukin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Asia-Pacific Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Asia-Pacific Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Proleukin Market

12.1. China Proleukin Market Overview

12.2. China Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

12.3. China Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

12.4. China Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Proleukin Market

13.1. India Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. India Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. India Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Proleukin Market

14.1. Japan Proleukin Market Overview

14.2. Japan Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. Japan Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. Japan Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Proleukin Market

15.1. Australia Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.2. Australia Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Australia Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Proleukin Market

16.1. South Korea Proleukin Market Overview

16.2. South Korea Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. South Korea Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.4. South Korea Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Proleukin Market

17.1. Western Europe Proleukin Market Overview

17.2. Western Europe Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Western Europe Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.4. Western Europe Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Proleukin Market

18.1. UK Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. UK Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. UK Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Proleukin Market

19.1. Germany Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Germany Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Germany Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Proleukin Market

20.1. France Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. France Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. France Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Proleukin Market

21.1. Eastern Europe Proleukin Market Overview

21.2. Eastern Europe Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Proleukin Market

22.1. North America Proleukin Market Overview

22.2. North America Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. North America Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.4. North America Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Proleukin Market

23.1. USA Proleukin Market Overview

23.2. USA Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. USA Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. USA Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Proleukin Market

24.1. Canada Proleukin Market Overview

24.2. Canada Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. Canada Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. Canada Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Proleukin Market

25.1. South America Proleukin Market Overview

25.2. South America Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. South America Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. South America Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Proleukin Market

26.1. Middle East Proleukin Market Overview

26.2. Middle East Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. Middle East Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. Middle East Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Proleukin Market

27.1. Africa Proleukin Market Overview

27.2. Africa Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Africa Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.4. Africa Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Proleukin Market Competitive Landscape And Company Profiles

28.1. Proleukin Market Competitive Landscape

28.2. Proleukin Market Company Profiles

28.2.1. Novartis Pharmaceuticals Corporation Overview, Products and Services, Strategy and Financial Analysis

29. Global Proleukin Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Proleukin Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Proleukin Market

32. Recent Developments In The Proleukin Market

33. Proleukin Market High Potential Countries, Segments and Strategies

33.1 Proleukin Market In 2029 - Countries Offering Most New Opportunities

33.2 Proleukin Market In 2029 - Segments Offering Most New Opportunities

33.3 Proleukin Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Proleukin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Proleukin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Proleukin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Proleukin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Asia-Pacific, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: China, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: India, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Japan, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Australia, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: South Korea, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: South Korea, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: South Korea, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Western Europe, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Western Europe, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Western Europe, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: UK, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: UK, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: UK, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Germany, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Germany, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Germany, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: France, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: France, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: France, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Eastern Europe, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Eastern Europe, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Eastern Europe, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: North America, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: North America, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: North America, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: USA, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: USA, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: USA, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Canada, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Canada, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Canada, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: South America, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: South America, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: South America, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Middle East, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Middle East, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Middle East, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Africa, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Africa, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: Africa, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: Novartis Pharmaceuticals Corporation Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Proleukin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Proleukin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Proleukin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Proleukin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Asia-Pacific, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: China, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: India, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Japan, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Australia, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: South Korea, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: South Korea, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: South Korea, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Western Europe, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Western Europe, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Western Europe, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: UK, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: UK, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: UK, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Germany, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Germany, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Germany, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: France, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: France, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: France, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Eastern Europe, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Eastern Europe, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Eastern Europe, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: North America, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: North America, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: North America, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: USA, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: USA, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: USA, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Canada, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Canada, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Canada, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: South America, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: South America, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: South America, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Middle East, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Middle East, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Middle East, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Africa, Proleukin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Africa, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: Africa, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: Novartis Pharmaceuticals Corporation Financial Performance

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

What Is The Compression Therapy Market Overview In 2022?

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the biologics market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the pegfilgrastim biosimilars market market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the hiv drugs market research report 2022 with industry size, share, segments and market growth

Biosimilar Interleukins Global Market Report 2025 – By Type (IL-17, IL-23, IL-1, IL-5, IL-6), By Application (Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Asthma, Inflammatory Bowel Disease (IBD), Other Applications), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Clinics, Research Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Interleukin Inhibitors Global Market Report 2025 – By Type (IL-17, IL-23, IL-1, IL-5, IL-6, Other Types), By Application (Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Asthma, Inflammatory Bowel Disease, Other Applications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

InterLeukin6 IL6 Inhibitor Global Market Report 2025 – By Drug Type (Tocilizumab, Siltuximab, Sylvant), By Route Of Administration (Intravenous (IV), Subcutaneous (SC), Other Route Of Administration), By Indication (Rheumatoid Arthritis, Oncology, Systemic Juvenile Idiopathic Arthritis, Giant Cell Arteritis, COVID-19-Related Cytokine Storm, Other Indications), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Specialty Pharmacies, Online Pharmacies, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Interstitial Lung Disease Global Market Report 2025 – By Drug Type (Oral Corticosteroids, Immune Suppressing, Anti-Fibrotic Medication, Other Drugs), By Disease Type (Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, Nonspecific Interstitial Pneumonitis, Hypersensitivity Pneumonitis, Cryptogenic Organizing Pneumonia (COP), Sarcoidosis, Acute Interstitial Pneumonitis), By Application (Adults, Children), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Interstitial Cystitis Global Market Report 2025 – By Treatment (Medications, Bladder Instillation, Botulinum Toxin A, Nerve Stimulation, Surgery), By Patient Type (Pediatric Patients, Adult Patients), By Drug Type (Over-The-Counter (OTC) Drugs, Prescription Drugs), By End User (Hospitals And Clinics, Homecare) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Brain Computer Interface Global Market Report 2025 – By Type (Invasive Brain Computer Interface, Partially Invasive Brain Computer Interface, Non Invasive Brain Computer Interface, Other Types), By Component (Hardware, Software), By Application (Healthcare, Disabilities Restoration, Brain Function Repair, Smart Home Control, Communication and Control, Entertainment and Gaming), By End-User (Medical, Military, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Acute Intermittent Porphyria Global Market Report 2025 – By Diagnosis (Urine Test, Blood Test, Serum Test, DNA Test, Other Diagnosis), By Treatment (Prophylactic Hematin Infusions, Gonadotropin-Releasing Hormone Analogues, Other Treatments), By End-Users (Hospitals And Clinics, Ambulatory Surgical Centers, Research Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Genomic Data Analysis And Interpretation Global Market Report 2025 – By Product (Software, Services), By Application (Functional Genomics, Real-time Polymerase Chain Reaction (PCR), Transfection, Single Nucleotide Polymorphisms (SNP) Analysis, Mutational Analysis, Microarray Analysis, Ribonucleic Acid (RNA) Interference, Pathway Analysis), By End User (Research And Academic Institutions, Biotechnology And Biopharmaceutical Companies, Hospitals And Diagnostic Laboratories, Contract Research Organizations, Forensic Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Proleukin market?

Proleukin is the brand name for aldesleukin, a recombinant form of interleukin-2 (IL-2), a naturally occurring protein in the body. Proleukin is classified as a biologic therapy and is primarily used in oncology and immunotherapy. It works by stimulating the growth and activity of certain white blood cells (lymphocytes), enhancing the immune system's ability to recognize and attack cancer cells. For further insights on the Proleukin market, request a sample here

How will the Proleukin market drivers and restraints affect the market dynamics? What forces will shape the Proleukin industry going forward?

The Proleukin market major growth driver - Rising Cancer Incidence Fuels Growth In The Proleukin Market. For further insights on the Proleukin market, request a sample here

What is the forecast market size or the forecast market value of the Proleukin market?

The Proleukin market size has grown strongly in recent years. The proleukin market size has grown strongly in recent years. It will grow from $1,165.73 million in 2024 to $1,242.46 million in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to increased availability of proleukin in global markets, increased insurance coverage for immunotherapy drugs, growth in physician acceptance of il-2-based treatments, surge in global cancer diagnostics, rising healthcare expenditure in oncology. The proleukin market size is expected to see strong growth in the next few years. It will grow to $1,581.28 million in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to rising demand for effective treatments in advanced cancer stages, growing demand for advanced treatments for rare cancers, growing clinical evidence supporting proleukin’s efficacy, increasing support from healthcare organizations for immuno-oncology treatments, increasing number of cancer patients. Major trends in the forecast period include advancements in biologic therapies, development of combination therapies using proleukin, technological advancements, strategic collaborations and partnerships, advancements in cancer vaccine development. For further insights on the Proleukin market, request a sample here

How is the Proleukin market segmented?

The proleukinmarket covered in this report is segmented –
1) By Type: Injection; Powder; Other Types
2) By Therapeutic Area: Oncology; Immunology; Other Therapeutic Areas
3) By Clinical Indication: Metastatic Renal Cell Carcinoma (RCC); Non-Small Cell Lung Cancer (NSCLC); Other Indications
4) By Application: Hospital; Pharmacy
5) By End-User: Adults; Pediatrics For further insights on the Proleukin market, request a sample here

Which region has the largest share of the Proleukin market? What are the other regions covered in the report?

Who are the major players in the Proleukin market?

Major companies operating in the proleukin market include Novartis Pharmaceuticals Corporation . For further insights on the Proleukin market, request a sample here.

What are the key trends in the Proleukin market?

Major trends in the Proleukin market include . For further insights on the Proleukin market, request a sample here.

What are the major opportunities in the Proleukin market? What are the strategies for the Proleukin market?

For detailed insights on the major opportunities and strategies in the Proleukin market, request a sample here.

How does the Proleukin market relate to the overall economy and other similar markets?

For detailed insights on Proleukin's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Proleukin industry?

For detailed insights on the mergers and acquisitions in the Proleukin industry, request a sample here.

What are the key dynamics influencing the Proleukin market growth? SWOT analysis of the Proleukin market.

For detailed insights on the key dynamics influencing the Proleukin market growth and SWOT analysis of the Proleukin industry, request a sample here.